Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 肺 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
富裕完成签到,获得积分10
1秒前
毛豆爸爸发布了新的文献求助10
1秒前
1秒前
桐桐的应助被积极的老鼠采纳,获得10
1秒前
2秒前
柔弱绝施发布了新的文献求助10
2秒前
小二郎的应助被随风采纳,获得10
3秒前
3秒前
熊逍完成签到,获得积分10
3秒前
脑洞疼的应助被忍蛙采纳,获得10
3秒前
风吹麦浪发布了新的文献求助10
3秒前
onemore发布了新的文献求助10
4秒前
拼搏的大地完成签到,获得积分10
5秒前
柔弱绝施完成签到,获得积分10
6秒前
6秒前
林狗发布了新的文献求助10
6秒前
7秒前
科研通AI6.2的应助被77采纳,获得10
7秒前
7秒前
MA的应助被远方采纳,获得30
7秒前
小二郎的应助被踏实采纳,获得10
7秒前
8秒前
8秒前
9秒前
积极的老鼠完成签到,获得积分10
9秒前
9秒前
9秒前
丘比特的应助被拼搏的大地采纳,获得10
10秒前
10秒前
zjl发布了新的文献求助10
10秒前
LithJude完成签到,获得积分10
10秒前
10秒前
chenyu完成签到,获得积分10
11秒前
11秒前
闪闪的采梦完成签到,获得积分10
11秒前
lzp发布了新的文献求助10
11秒前
12秒前
游舒平发布了新的文献求助30
13秒前
Renata发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
Organizational Behavior 510
Management and the Arts 510
Convergent and bidirectional strategies towards the total synthesis of hemibrevetoxin B 300
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7796364
求助须知:如何正确求助?哪些是违规求助? 9332098
关于积分的说明 20447542
捐赠科研通 7386737
什么是DOI,文献DOI怎么找? 3324973
关于科研通互助平台的介绍 2472291
邀请新用户注册赠送积分活动 2342129